-
1
-
-
43649093915
-
Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway
-
Kaelin WG, Jr., Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008;30:393-402.
-
(2008)
Mol Cell
, vol.30
, pp. 393-402
-
-
Kaelin Jr., W.G.1
Ratcliffe, P.J.2
-
2
-
-
38149059911
-
Mitochondria and cellular oxygen sensing in the HIF pathway
-
Taylor CT. Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem J 2008;409:19-26.
-
(2008)
Biochem J
, vol.409
, pp. 19-26
-
-
Taylor, C.T.1
-
3
-
-
57649148810
-
Mitochondria and hypoxia-induced gene expression mediated by hypoxia-inducible factors
-
Chavez A, Miranda LF, Pichiule P, Chavez JC. Mitochondria and hypoxia-induced gene expression mediated by hypoxia-inducible factors. Ann NY Acad Sci 2008;1147:312-320.
-
(2008)
Ann NY Acad Sci
, vol.1147
, pp. 312-320
-
-
Chavez, A.1
Miranda, L.F.2
Pichiule, P.3
Chavez, J.C.4
-
4
-
-
54549113030
-
The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer
-
Kaelin WG, Jr. The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer 2008;8:865-873.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 865-873
-
-
Kaelin Jr., W.G.1
-
5
-
-
59449093593
-
Vascular endothelial growth factors in cardiovascular medicine
-
Testa U, Pannitteri G, Condorelli GL. Vascular endothelial growth factors in cardiovascular medicine. J Cardiovasc Med 2008;9:1190-1221.
-
(2008)
J Cardiovasc Med
, vol.9
, pp. 1190-1221
-
-
Testa, U.1
Pannitteri, G.2
Condorelli, G.L.3
-
6
-
-
62349106788
-
Nonrenal regulation of EPO synthesis
-
Weidemann A, Johnson RS. Nonrenal regulation of EPO synthesis. Kidney Int 2009;75:682-688.
-
(2009)
Kidney Int
, vol.75
, pp. 682-688
-
-
Weidemann, A.1
Johnson, R.S.2
-
7
-
-
20044373442
-
Emerging biological roles for erythropoietin in the nervous system
-
Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system Nat Rev Neurosci 2005;6:484-494.
-
(2005)
Nat Rev Neurosci
, vol.6
, pp. 484-494
-
-
Brines, M.1
Cerami, A.2
-
8
-
-
4644318784
-
Erythropoietin and the hypoxic brain
-
Marti HH. Erythropoietin and the hypoxic brain. J Exp Biol 2004;207:3233-3242.
-
(2004)
J Exp Biol
, vol.207
, pp. 3233-3242
-
-
Marti, H.H.1
-
9
-
-
57049145362
-
Brain protection by erythropoietin: A manifold task
-
Rabie T, Marti HH. Brain protection by erythropoietin: a manifold task. Physiology 2008;23:263-274.
-
(2008)
Physiology
, vol.23
, pp. 263-274
-
-
Rabie, T.1
Marti, H.H.2
-
10
-
-
34447632643
-
Angiogenesis in brain tumours
-
Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. Angiogenesis in brain tumours. Nat Rev Neurosci 2007;8:610-622.
-
(2007)
Nat Rev Neurosci
, vol.8
, pp. 610-622
-
-
Jain, R.K.1
Di Tomaso, E.2
Duda, D.G.3
Loeffler, J.S.4
Sorensen, A.G.5
Batchelor, T.T.6
-
11
-
-
34548669593
-
Central nervous system capillary haemangioblastoma: The pathologist's viewpoint
-
Hussein, MR. Central nervous system capillary haemangioblastoma: the pathologist's viewpoint Int J Exp Pathol 2007;88:311-324.
-
(2007)
Int J Exp Pathol
, vol.88
, pp. 311-324
-
-
Hussein, M.R.1
-
12
-
-
55849130720
-
Novel anti-angiogenic therapies for malignant gliomas
-
Norden AD, Drappatz J, Wen PY. Novel anti-angiogenic therapies for malignant gliomas. Lancet Neurol 2008;7:1152-1160.
-
(2008)
Lancet Neurol
, vol.7
, pp. 1152-1160
-
-
Norden, A.D.1
Drappatz, J.2
Wen, P.Y.3
-
13
-
-
53749093232
-
Neuroprotective properties and mechanisms of erythropoietin in vitro and in vivo experimental models for hypoxia/ischemia
-
van der Kooij MA, Groenendaal F, Kavelaars A, Heijnen CJ, van Bel F. Neuroprotective properties and mechanisms of erythropoietin in vitro and in vivo experimental models for hypoxia/ischemia. Brain Res Rev 2008;59:22-33.
-
(2008)
Brain Res Rev
, vol.59
, pp. 22-33
-
-
Van Der Kooij, M.A.1
Groenendaal, F.2
Kavelaars, A.3
Heijnen, C.J.4
Van Bel, F.5
-
14
-
-
48249108760
-
Therapeutic strategy of erythropoietin in neurological disorders
-
Liu XB, Wang JA, Yu SP, Keogh CL, Wei L. Therapeutic strategy of erythropoietin in neurological disorders. CNS Neurol Disord Drug Targets 2008;7:227-234.
-
(2008)
CNS Neurol Disord Drug Targets
, vol.7
, pp. 227-234
-
-
Liu, X.B.1
Wang, J.A.2
Yu, S.P.3
Keogh, C.L.4
Wei, L.5
-
15
-
-
57749116047
-
Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system
-
Siren AL, Fasshauer T, Bartels C, Ehrenreich H. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics 2009;6:108-127.
-
(2009)
Neurotherapeutics
, vol.6
, pp. 108-127
-
-
Siren, A.L.1
Fasshauer, T.2
Bartels, C.3
Ehrenreich, H.4
-
16
-
-
69649087177
-
VEGF protects motor neurons against excitotoxicity by upregulation of GluR2
-
Jan 28
-
Bogaert E, Van Damme P, Poesen K, et al. VEGF protects motor neurons against excitotoxicity by upregulation of GluR2. Neurobiol Aging Epub 2009 Jan 28.
-
(2009)
Neurobiol Aging Epub
-
-
Bogaert, E.1
Van Damme, P.2
Poesen, K.3
-
17
-
-
60349086984
-
Vascular endothelial growth factor protects motoneurons from serum deprivation-induced cell death through phosphatidylinositol 3-kinase-mediated p38 mitogen-activated protein kinase inhibition
-
Tolosa L, Mir M, Olmos G, Llado J. Vascular endothelial growth factor protects motoneurons from serum deprivation-induced cell death through phosphatidylinositol 3-kinase-mediated p38 mitogen-activated protein kinase inhibition. Neuroscience 2009;158:1348-1355.
-
(2009)
Neuroscience
, vol.158
, pp. 1348-1355
-
-
Tolosa, L.1
Mir, M.2
Olmos, G.3
Llado, J.4
-
18
-
-
53549104744
-
Erythropoietin enhances hippocampal long-term potentiation and memory
-
Adamcio B, Sargin D, Stradomska A, et al. Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biol 2008;6:37.
-
(2008)
BMC Biol
, vol.6
, pp. 37
-
-
Adamcio, B.1
Sargin, D.2
Stradomska, A.3
-
19
-
-
60849139085
-
Metabolic enzymes as oncogenes or tumor suppressors
-
Thompson CB. Metabolic enzymes as oncogenes or tumor suppressors. N Engl J Med 2009;360:813-815.
-
(2009)
N Engl J Med
, vol.360
, pp. 813-815
-
-
Thompson, C.B.1
-
20
-
-
54949146824
-
Malignant gliomas in adults
-
author reply 1850
-
Meyer MA. Malignant gliomas in adults. N Engl J Med 2008;359:1850; author reply 1850.
-
(2008)
N Engl J Med
, vol.359
, pp. 1850
-
-
Meyer, M.A.1
-
21
-
-
49749122191
-
Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay
-
Knizetova P, Ehrmann J, Hlobilkova A, et al. Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay. Cell Cycle 2008;7:2553-2561.
-
(2008)
Cell Cycle
, vol.7
, pp. 2553-2561
-
-
Knizetova, P.1
Ehrmann, J.2
Hlobilkova, A.3
-
22
-
-
52949127312
-
An integrated genomic analysis of human glioblastoma multiforme
-
Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008;321:1807-1812.
-
(2008)
Science
, vol.321
, pp. 1807-1812
-
-
Parsons, D.W.1
Jones, S.2
Zhang, X.3
-
23
-
-
60849115270
-
IDH1 and IDH2 mutations in gliomas
-
Yan H, Parsons DW, Jin G, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009;360:765-773.
-
(2009)
N Engl J Med
, vol.360
, pp. 765-773
-
-
Yan, H.1
Parsons, D.W.2
Jin, G.3
-
24
-
-
38649111639
-
VEGF and osteosclerosis in POEMS syndrome
-
Gutgemann I, Stevens K, Loftus D, Schmidt-Wolf IG, George TI. VEGF and osteosclerosis in POEMS syndrome. Ann Hematol 2008;87:243-245.
-
(2008)
Ann Hematol
, vol.87
, pp. 243-245
-
-
Gutgemann, I.1
Stevens, K.2
Loftus, D.3
Schmidt-Wolf, I.G.4
George, T.I.5
-
25
-
-
34948909599
-
Vascular endothelial growth factor prevents paralysis and motoneuron death in a rat model of excitotoxic spinal cord neurodegeneration
-
DOI 10.1097/nen.0b013e3181567c16, PII 0000507220071000000005
-
Tovar YRLB, Zepeda A, Tapia R. Vascular endothelial growth factor prevents paralysis and motoneuron death in a rat model of excitotoxic spinal cord neurodegeneration. J Neuropathol Exp Neurol 2007;66:913-922. (Pubitemid 47530830)
-
(2007)
Journal of Neuropathology and Experimental Neurology
, vol.66
, Issue.10
, pp. 913-922
-
-
Tovar-Y-Romo, L.B.1
Zepeda, A.2
Tapia, R.3
-
26
-
-
58549102138
-
Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial growth factor 3′-untranslated region
-
Li X, Lu L, Bush DJ, et al. Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial growth factor 3′-untranslated region. J Neurochem 2009;108:1032-1044.
-
(2009)
J Neurochem
, vol.108
, pp. 1032-1044
-
-
Li, X.1
Lu, L.2
Bush, D.J.3
-
27
-
-
54849424014
-
Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration
-
Poesen K, Lambrechts D, Van Damme P, et al. Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration. J Neurosci 2008;28:10451-10459.
-
(2008)
J Neurosci
, vol.28
, pp. 10451-10459
-
-
Poesen, K.1
Lambrechts, D.2
Van Damme, P.3
-
28
-
-
50449086167
-
VEGF and ALS
-
Sathasivam S. VEGF and ALS. Neurosci Res 2008;62:71-77.
-
(2008)
Neurosci Res
, vol.62
, pp. 71-77
-
-
Sathasivam, S.1
-
29
-
-
33644913172
-
Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis
-
DOI 10.1097/01.jnen.0000196134.51217.74, PII 0000507220060100000004
-
Brockington A, Wharton SB, Fernando M, et al. Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2006;65:26-36. (Pubitemid 43755387)
-
(2006)
Journal of Neuropathology and Experimental Neurology
, vol.65
, Issue.1
, pp. 26-36
-
-
Brockington, A.1
Wharton, S.B.2
Fernando, M.3
Gelsthorpe, C.H.4
Baxter, L.5
Ince, P.G.6
Lewis, C.E.7
Shaw, P.J.8
-
30
-
-
54049149014
-
Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of amyotrophic lateral sclerosis
-
Takahashi Y, Seki N, Ishiura H, et al. Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of amyotrophic lateral sclerosis. Arch Neurol 2008;65:1326-1332.
-
(2008)
Arch Neurol
, vol.65
, pp. 1326-1332
-
-
Takahashi, Y.1
Seki, N.2
Ishiura, H.3
-
31
-
-
67651148186
-
CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients
-
Moreau C, Gosset P, Brunaud-Danel V, et al. CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients. Amyotroph Lateral Scler 2009;10:1-7.
-
(2009)
Amyotroph Lateral Scler
, vol.10
, pp. 1-7
-
-
Moreau, C.1
Gosset, P.2
Brunaud-Danel, V.3
-
32
-
-
50449094713
-
Meta-analysis of VEGF variations in ALS: Increased susceptibility in male carriers of the -2578AA genotype
-
Jul 17
-
Lambrechts D, Poesen K, Fernandez-Santiago R, et al. Meta-analysis of VEGF variations in ALS: increased susceptibility in male carriers of the -2578AA genotype. J Med Genet Epub 2008 Jul 17.
-
(2008)
J Med Genet Epub
-
-
Lambrechts, D.1
Poesen, K.2
Fernandez-Santiago, R.3
-
33
-
-
33745763116
-
Cerebral preconditioning and ischaemic tolerance
-
Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 2006;7:437-448.
-
(2006)
Nat Rev Neurosci
, vol.7
, pp. 437-448
-
-
Gidday, J.M.1
-
35
-
-
57649219163
-
Post-ischemic brain damage: Effect of ischemic preconditioning and postconditioning and identification of potential candidates for stroke therapy
-
Pignataro G, Scorziello A, Di Renzo G, Annunziato L. Post-ischemic brain damage: effect of ischemic preconditioning and postconditioning and identification of potential candidates for stroke therapy. FEBS J 2009;276:46-57.
-
(2009)
FEBS J
, vol.276
, pp. 46-57
-
-
Pignataro, G.1
Scorziello, A.2
Di Renzo, G.3
Annunziato, L.4
-
36
-
-
18744389551
-
Hypoxic Preconditioning Protects against Ischemic Brain Injury
-
DOI 10.1602/neurorx.1.1.26, PII S1545534306700050
-
Sharp FR, Ran R, Lu A, et al. Hypoxic preconditioning protects against ischemic brain injury. NeuroRx 2004;1:26-35. (Pubitemid 46613775)
-
(2004)
NeuroRx
, vol.1
, Issue.1
, pp. 26-35
-
-
Sharp, F.R.1
Ran, R.2
Lu, A.3
Tang, Y.4
Strauss, K.I.5
Glass, T.6
Ardizzone, T.7
Bernaudin, M.8
-
37
-
-
0036211764
-
Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain
-
Bernaudin M, Nedelec AS, Divoux D, MacKenzie ET, Petit E, Schumann-Bard P. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 2002;22:393-403. (Pubitemid 34273595)
-
(2002)
Journal of Cerebral Blood Flow and Metabolism
, vol.22
, Issue.4
, pp. 393-403
-
-
Bernaudin, M.1
Nedelec, A.-S.2
Divoux, D.3
MacKenzie, E.T.4
Petit, E.5
Schumann-Bard, P.6
-
38
-
-
29144475158
-
Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: Identification of potential neuroprotective candidates for stroke
-
DOI 10.1016/j.nbd.2005.06.002, PII S0969996105001683
-
Tang Y, Pacary E, Freret T, et al. Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: identification of potential neuroprotective candidates for stroke. Neurobiol Dis 2006;21:18-28. (Pubitemid 41817301)
-
(2006)
Neurobiology of Disease
, vol.21
, Issue.1
, pp. 18-28
-
-
Tang, Y.1
Pacary, E.2
Freret, T.3
Divoux, D.4
Petit, E.5
Schumann-Bard, P.6
Bernaudin, M.7
-
39
-
-
62549102923
-
Preconditioning and tolerance against cerebral ischaemia: From experimental strategies to clinical use
-
Dirnagl U, Becker K, Meisel, A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 2009;8:398-412.
-
(2009)
Lancet Neurol
, vol.8
, pp. 398-412
-
-
Dirnagl, U.1
Becker, K.2
Meisel, A.3
-
40
-
-
60849093177
-
Erythropoietin modulation of astrocyte water permeability as a component of neuroprotection
-
Gunnarson E, Song Y, Kowalewski JM, et al. Erythropoietin modulation of astrocyte water permeability as a component of neuroprotection. Proc Natl Acad Sci USA 2009;106:1602-1607.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 1602-1607
-
-
Gunnarson, E.1
Song, Y.2
Kowalewski, J.M.3
-
41
-
-
29244485561
-
Hypoxia-inducible factor prolyl 4-hydroxylase inhibition: A target for neuroprotection in the central nervous system
-
DOI 10.1074/jbc.M504963200
-
Siddiq A, Ayoub IA, Chavez JC, et al. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition: a target for neuroprotection in the central nervous system. J Biol Chem 2005;280:41732-41743. (Pubitemid 41832236)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.50
, pp. 41732-41743
-
-
Siddiq, A.1
Ayoub, I.A.2
Chavez, J.C.3
Aminova, L.4
Shah, S.5
Lamanna, J.C.6
Patton, S.M.7
Connor, J.R.8
Cherny, R.A.9
Volitakis, I.10
Bush, A.I.11
Langsetmo, I.12
Seeley, T.13
Gunzler, V.14
Ratan, R.R.15
-
42
-
-
57649233071
-
Small molecule activation of adaptive gene expression: Tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury
-
Ratan RR, Siddiq A, Aminova L, et al. Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury. Ann NY Acad Sci 2008;1147:383-394.
-
(2008)
Ann NY Acad Sci
, vol.1147
, pp. 383-394
-
-
Ratan, R.R.1
Siddiq, A.2
Aminova, L.3
-
43
-
-
3843124229
-
A novel role for an established player: Anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemia
-
DOI 10.1016/j.transci.2004.05.001, PII S1473050204000850
-
Ehrenreich H, Timner W, Siren AL. A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemia. Transfus Apher Sci 2004;31:39-44. (Pubitemid 39044370)
-
(2004)
Transfusion and Apheresis Science
, vol.31
, Issue.1
, pp. 39-44
-
-
Ehrenreich, H.1
Timner, W.2
Siren, A.-L.3
|